glutathione reductase chronic granulomatous disease Participation in the Prevention of Cardiovascular Diseases Chronic Granulomatous Disease – Biochemistry

Further investigation is clearly warranted to comprehensively elucidate the mechanisms of acquired resistance to obtain optimal treatment options

3) Free-Choice Training (35 days, 10 trials/day, 2 min/trial): Each session began with one HR and one LR forced-choice trial to reinforce associations, followed by 10 free-choice trials with recorded arm selections

Then, a second PCR was performed to validate the correct genomic integration of the transgene (degron sequence) using primers over 1 kb upstream and downstream the homology arms (outside the region corresponding to the targeting vector) and by using a Phusion Plus DNA Polymerase (Thermo Fisher, #F630S)

[Google Scholar] Zimmer R